Clinical Trial Update: Sitagliptin in Renal Transplant Recipients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating sitagliptin for glucose intolerance in renal transplant recipients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glucose Intolerance

Drugs mentioned

• Sitagliptin (sitagliptin)

Snippet

Sponsor: University of Oslo School of Pharmacy | Conditions: Glucose Intolerance | Phase 4 | Status: COMPLETED